Powering implantable restriction systems using light

• US 7,844,342 B2
• Filed: 02/07/2008
• Issued: 11/30/2010
• Est. Priority Date: 02/07/2008
• Status: Active Grant

• Current Assignee: Ethicon Endo-Surgery, Inc. (Johnson & Johnson)
• Original Assignee: Ethicon Endo-Surgery, Inc. (Johnson & Johnson)
• Inventors: Dlugos, Daniel F. Jr., Ortiz, Mark S., Stokes, Michael J., Plescia, David N.
• Primary Examiner(s): Manuel; George
• Assistant Examiner(s): Narayanaswamy; Shubatra
• Application Number:
  US12/027,784
• Publication Number:
  US 20090204178A1
• Time in Patent Office: 1,027 Days
• Field of Search: 600/37, 607/61
• US Class Current: 607/61
• CPC Class Codes: A61F 5/0059 with wireless means

Abstract

Various powering devices are provided for transferring and/or generating energy from numerous sources to a communicating member implanted in a patient. The energy transferred to or generated by the communicating member can be used to provide power to an implantable restriction system configured to form a restriction in a pathway.

Claims

1. A system for forming a restriction in a patient, comprising:

an implantable restriction device adapted to form a restriction in a patient, the implantable restriction device including a fluid injection port configured to allow fluid to be introduced into and removed from the restriction device to alter the amount of restriction provided by the restriction device and a communicating member disposed within the fluid injection port and adapted to receive light waves and to convert the light waves into energy that powers the implantable restriction device.

2. The system of claim 1, further comprising an external energy transfer apparatus having a light source operable to communicate the light waves to the communicating member.

3. The system of claim 2, wherein the external energy transfer apparatus includes a gauge effective to indicate whether the light waves are being communicated between the light source and the communicating member effective to power the implantable restriction device.

4. The system of claim 2, wherein the light source emits light selected from the group consisting of infrared light waves in a range of about 0.75 μ

m to 1,000 μ

m, visible light waves in a range of about 400 nm to 750 nm, and ultraviolet light waves in a range of about 280 nm to 400 nm.

5. The system of claim 1, wherein the communicating member comprises a photovoltaic cell array or silicon nanowire bundle.

6. The system of claim 1, wherein the communicating member comprises a crystalline silicon cell array.

7. The system of claim 1, wherein the implantable restriction device comprises a the gastric band and a housing in communication with the gastric band.

8. The system of claim 7, wherein the communicating member is disposed in the housing.

9. The system of claim 1, wherein the communicating member is configured to receive and transmit data.

10. A method for providing power to an implantable restriction device, comprising:

activating a light source to transfer light through tissue to a communicating member disposed within a fluid injection port of an implantable restriction device implanted in a patient to form a restriction in a pathway, the communicating member converting the light to electrical power or energy to power the implantable restriction device.

11. The method of claim 10, wherein the light source is on an external device, and the method further comprises positioning the external device adjacent to a skin surface and in proximity to the communicating member implanted within tissue.

12. The method of claim 11, wherein the external device receives data from the communicating member, the data including at least one measurement of pressure of fluid within the implantable restriction device.

13. The method of claim 11, wherein the external device includes a gauge that indicates whether the light being transferred between the light source and the communicating member is effective to power the implantable restriction device.

14. The method of claim 10, wherein the communicating member comprises a photovoltaic cell array or silicon nanowire bundle.

15. The method of claim 10, wherein the communicating member comprises a crystalline silicon cell array.

16. The method of claim 10, wherein the light source emits light selected from the group consisting of infrared light with a wavelength in a range of about 0.70 μ

m to 1,000 μ

m, visible light with a wavelength in a range of about 400 nm to 750 nm, and ultraviolet light with a wavelength in the range of about 280 nm to 400 nm.

17. The method of claim 10, wherein the implantable restriction device comprises a gastric band disposed around a stomach to form a restriction, and a housing in communication with the gastric band.